79752-03-7 Usage
Uses
Used in Pharmaceutical Industry:
1-(3-Nitro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)ethanone is used as a psychoactive medication for the treatment of anxiety, insomnia, and other related conditions. Its anxiolytic and sedative properties, along with its ability to enhance GABA activity in the brain, make it a potent and effective medication for managing these conditions.
1-(3-Nitro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)ethanone is also used as an anti-convulsant medication for the management of epilepsy and other seizure disorders. Its ability to modulate GABA activity in the brain contributes to its effectiveness in controlling seizures and preventing their recurrence.
Check Digit Verification of cas no
The CAS Registry Mumber 79752-03-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,9,7,5 and 2 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 79752-03:
(7*7)+(6*9)+(5*7)+(4*5)+(3*2)+(2*0)+(1*3)=167
167 % 10 = 7
So 79752-03-7 is a valid CAS Registry Number.
InChI:InChI=1/C16H14N2O3/c1-11(19)17-15-5-3-2-4-12(15)6-7-13-8-9-14(18(20)21)10-16(13)17/h2-5,8-10H,6-7H2,1H3
79752-03-7Relevant academic research and scientific papers
SELECTIVE INHIBITORS OF CONSTITUTIVE ANDROSTANE RECEPTOR
-
Paragraph 00553, (2016/05/24)
The compounds of the invention are antagonists of CAR, with specificity for CAR over other proteins including PXR. The disclosed compounds are useful in treating or controlling cell proliferative disorders, in particular oncological disorders, such as cancer. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
RESEARCH ON TUMOUR INHIBITING COMPOUNDS. PART LXV. SYNTHESES OF NITRO-10,11-DIHYDRO-5H-DIBENZAZEPINES AND THEIR DERIVATIVES
Horowska, Barbara,Ledochowski, Andrzej
, p. 39 - 46 (2007/10/02)
Syntheses of several derivatives of 10,11-dihydro-5H-dibenzazepine are reported.
